Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Gritstone Oncology Inc (NASDAQ:GRTS) Begins Phase 1 Clinical Study Of COVID-19…
Timber Pharmaceuticals Inc (NYSE:TMBR) Receives ODD For TMB-003 From The US…
CASI Pharmaceuticals Inc (NASDAQ:CASI) Reports A Growth Of 265% YoY In…
NovaBay Pharmaceuticals (NYSE:NBY) Reports Revenues Of $1.9 Million In Q4 2020:…
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Interim Results From Phase 2…
Finance
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Moderna Inc (NASDAQ:MRNA) Signs Deal With Baxter International Inc (NYSE:BAX) For…
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Gilead Sciences Inc.
Tag: Gilead Sciences Inc.
Gilead Sciences Inc. (NASDAQ:GILD) Receives FDA Approval For Remdesivir In Treating...
Matt Wade
-
October 27, 2020
0
Gilead Sciences Inc. (NASDAQ:GILD) Announce $21 Billion Acquisition Of Cancer Drug...
Ward Sport
-
September 22, 2020
0
Gilead Sciences, Inc. (NASDAQ:GILD) Announces a Licensing Pact with Jounce Therapeutics...
Kate Hudson
-
September 9, 2020
0
.td-post-views{ display: none !important; }
